abciximab   Click here for help

GtoPdb Ligand ID: 6584

Synonyms: 7E3 antibody | antiGPIIBIIIa | C7E3 | ReoPro®
Approved drug
abciximab is an approved drug (FDA (1994))
Compound class: Antibody
Comment: Abciximab is a chimeric human-murine monoclonal antibody Fab (fragment antigen binding) fragment designed to target glycoprotein IIb/IIIa receptor, a key mediator of platelet aggregation and clot formation [2]. The invention of abciximab is covered by patent US5976532 [1], where its originating antibody is coded c7E3.
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: abciximab

Classification Click here for help
Compound class Antibody
Approved drug? Yes (FDA (1994))
International Nonproprietary Names Click here for help
INN number INN
7200 abciximab
Synonyms Click here for help
7E3 antibody | antiGPIIBIIIa | C7E3 | ReoPro®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 146
Other databases
GtoPdb PubChem SID 178103197
PubChem SID 178103197
Search PubMed clinical trials abciximab
Search PubMed titles abciximab
Search PubMed titles/abstracts abciximab
Wikipedia Abciximab